MG-K10 for chronic hives not controlled by antihistamines
Treatments studied
Part of Immune system & allergy, Skin clinical trials.
This study tests a new medication called MG-K10 for people with chronic hives (itchy welts) that don't go away with standard antihistamines. It aims to see if the drug can reduce itching and hives, possibly offering another treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 12 to 75 years old, weighing at least 30 kg (about 66 lbs)
- Diagnosed with chronic hives for at least 6 months, with ongoing symptoms despite antihistamines
- Have a certain level of itch and hives (checked by your doctor) within the last week
- Willing to keep taking your usual antihistamines (up to 4 times the normal dose) during the study
- Agree to use reliable birth control during the study and for 6 months after the last dose
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new injection (CM512) for people with chronic spontaneous urticaria, also known as chronic hives. If you have had itchy hives for at least 6 weeks despite taking regular antihistamines, this study may help find a new treatment option.
This trial tests a new oral medication for chronic spontaneous urticaria (chronic hives). It is a placebo-controlled study, meaning some participants will get the new drug and some will get a placebo (a pill with no active ingredient). The goal is to see if the new drug is safe and how well it works, possibly providing a new treatment option for those whose hives are not controlled by current antihistamines.
This study tests a new oral medication (TLL-018) for people with chronic hives that don't fully go away with standard antihistamines. It aims to see if the drug reduces itching and hives better than placebo.
This trial tests a new daily pill called TLL-018 (a JAK inhibitor) for people with chronic hives that still cause symptoms despite taking antihistamines. It aims to see how fast it relieves itching and hives.
This study tests an investigational pill called THB335 for adults whose hives (itchy welts) keep appearing despite taking antihistamines. The goal is to see if this treatment can reduce itching and hives and improve quality of life.
This trial tests an experimental drug called ICP-332 for people with chronic spontaneous urticaria (long-term hives) that is not well controlled by standard antihistamines. The goal is to see if the drug is safe and effective at reducing hives.
Hear when a new Chronic Spontaneous Urticaria (CSU) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.